logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PDU-6. Estimated trends in the prevalence of problem and injecting drug use, 2006–11 (rate per 1 000 population aged 15–64): Combined estimates per country

Part (iv) Estimated trends of problem stimulant use

Country200620072008200920102011Drug use [1]Method [1]
Czech Republic2.692.842.873.413.814.24PSUTM
Italy4.084.294.44.50:PSUTM
Slovakia2.22.080.83::PSUOT
 

Notes:

Data represents a selection based on the availability of the same calculation method over the time. In some countries more estimates might be available. The selection was made in order for the trend to be unbiased. In some countries data are insufficient to report.

Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution.

For more details see Tables PDU-1, PDU-102 and PDU-103 in the Statistical bulletin 2013.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page

See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich.

[1] - POU = Problem opioid use; PSU = Problem stimulant use; IDU = Injecting drug use; PDU = Problem drug use. TM = Treatment Multiplier ; HM = HIV Multiplier ; MM = Mortality Multiplier ; MI = Multivariate Indicator Method ; PM = Police Multiplier ; TP = Truncated Poisson ; CM = Combined Methods. CR = Capture Recapture, OT = Other Methods.

Sources:

Reitox national focal points

2013 REITOX National Reports - Fonte PDU template

Page last updated: Friday, 26 April 2013